• Non ci sono risultati.

Kenneth B. Gordon Eric M. Ruderman Editors Psoriasis and Psoriatic Arthritis An Integrated Approach

N/A
N/A
Protected

Academic year: 2021

Condividi "Kenneth B. Gordon Eric M. Ruderman Editors Psoriasis and Psoriatic Arthritis An Integrated Approach"

Copied!
10
0
0

Testo completo

(1)

Kenneth B. Gordon Eric M. Ruderman Editors

Psoriasis and Psoriatic Arthritis

An Integrated Approach

(2)

Kenneth B. Gordon Eric M. Ruderman Editors

Psoriasis and

Psoriatic Arthritis

An Integrated Approach

With 47 Figures and 36 Tables

(3)

Kenneth B. Gordon, MD Division of Dermatology Loyola University

Stritch School of Medicine

2160 S. First Ave., Building 112, Room 342 Maywood, IL 60153

USA

Eric M. Ruderman, MD Division of Rheumatology Northwestern University Feinberg School of Medicine 675 N. St. Clair St.

Chicago, IL 60611 USA

Library of Congress Control Number: 2004113294 ISBN 3-540-21280-9 Springer Berlin Heidelberg New York

This work is subject to copyright. All rights are reserved, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcast- ing, reproduction on microfilm or in any other way, and storage in data banks. Duplication of this pub- lication or parts thereof is permitted only under the provisions of the German Copyright Law of September 9, 1965, in its current version, and permission for use must always be obtained from Springer. Violations are liable to prosecution under the German Copyright Law.

Springer is a part of Springer Science+Business Media springeronline.com

© Springer-Verlag Berlin Heidelberg 2005 Printed in Germany

The use of general descriptive names, registered names, trademarks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant pro- tective laws and regulations and therefore free for general use.

Product liability: the publishers cannot guarantee the accuracy of any information about dosage and application contained in this book. In every individual case the user must check such information by consulting the relevant literature.

Editor: Marion Philipp Desk Editor: Irmela Bohn

Production: ProEdit GmbH, 69126 Heidelberg, Germany Cover: Frido Steinen-Broo, EStudio Calamar, Spain Typesetting: K. Detzner, 67346 Speyer, Germany Printed on acid-free paper 21/3150 ML 5 4 3 2 1 0

(4)

Dermatologists and rheumatologists alike are confronted with patients suffering from both psoriasis and psoriatic arthritis, and are often asked to address the dis- ease with which they are least familiar. In our experience, proper care of either ail- ment requires a working knowledge of both. Working together to manage these pa- tients, we have found that the most effective treatments must account for all mani- festations of disease, whether skin or joint, and that this approach is the best way to ensure satisfied patients with the most unrestricted quality of life.

Our goal with this book is to bring current information about psoriasis and psor- iatic arthritis together in a form that is useful for a satisfactory understanding of the pathophysiology, clinical aspects, and therapy of both diseases. Ideally, the integrat- ed approach of this text will give specialists the necessary tools to work together ef- fectively in the same office or in consultation. While this type of coordinated care strikes us as the best approach, we recognize that all dermatologists and rheumatol- ogists will not have this luxury, and we hope this book will also serve as a useful re- view of those disease elements both within and outside the reader's own area of ex- pertise.

This book is dedicated to our families: Dafna, Danny, and Jake Gordon, and Stacey Empson and Lucy Ruderman. We thank them for their patience in helping us through this endeavor.

Kenneth B. Gordon, MD Eric M. Ruderman, MD December 2004

Preface

(5)

Contents

I Introduction . . . . 1 Kenneth B. Gordon, Eric M. Ruderman

II Genetics . . . . 3 A. Psoriasis . . . . 3

Mahreen Ameen, Jonathan N.W.N. Barker

B. Psoriatic Arthritis . . . . 12 Proton Rahman, Dafna D. Gladman

III Immunopathogenesis . . . . 23 A. Psoriasis . . . . 23

Brian K. Bonish, Brian J. Nickoloff

B. Psoriatic Arthritis . . . . 36 Jennifer Barton, Christopher T. Ritchlin

IV Epidemiology . . . . 47 A. Psoriasis . . . . 47

Christine C. Jacobson, Alexa B. Kimball

B. Psoriatic Arthritis . . . . 57 Dafna D. Gladman

V Clinical Presentation . . . . 67 A. Psoriasis . . . . 67

Jennifer Soung, Mark Lebwohl

B. Psoriatic Arthritis . . . . 73

Philip S. Helliwell

(6)

Contents VIII

VI Diagnostic Evaluation . . . . 83 A. Psoriasis . . . . 83

Bettina M. Prinz Vavricka, Joan Guitart

B. Psoriatic Arthritis . . . . 95 Soumya M. Reddy, Clifton O. Bingham III

VII Quality of Life . . . 109 A. Psoriasis . . . 109

Steven R. Feldman, Stephen R. Rapp

B. Psoriatic Arthritis . . . 118 Dafna D. Gladman

VIII Clinical Outcome Measurements . . . 125 A. Psoriasis . . . 125

Kenneth B. Gordon

B. Psoriatic Arthritis . . . 129 Soumya M. Reddy, Clifton O. Bingham III

IX Conventional Therapy . . . 133 A. Psoriasis . . . 133 1. Topical Therapy . . . 134

Rachel Quinby

2. Phototherapy . . . 145 Jennifer Dempsey, Michael Zanolli

3. Systemic Retinoids . . . 158 Milan J. Anadkat, Michael P. Heffernan

4. Methotrexate and Cyclosporine . . . 172 Jennifer C. Cather, Alan Menter

B. Psoriatic Arthritis . . . 185

Christopher G. Jackson, Daniel O. Clegg

(7)

Contents IX

X Biologic Therapy . . . 193 A. Psoriasis . . . 193 1. Anti-T-Cell Agents . . . 193

Richard G.B. Langley, Christa L. Doherty, Scott J. Murray

2. TNF Antagonist Therapy . . . 208 Bruce E. Strober . . . . B. Psoriatic Arthritis . . . 223

1. TNF α Inhibitors in Psoriatic Arthritis . . . 223 Philip J. Mease

2. Other Biologic Therapy . . . 234 Ja Huen Jung, Zuhre Tutuncu, Arthur F. Kavanaugh

XI Synthesis and Conclusion . . . 245 Kenneth B. Gordon, Eric M. Ruderman

Subject Index . . . 251

(8)

List of Contributors

Mahreen Ameen

St. Johns Institute of Dermatology St. Thomas’ Hospital

London UK

Milan J. Anadkat, MD Division of Dermatology

Washington University School of Medicine St. Louis, MO

USA

Jonathan N.W.N. Barker, MD St. Johns Institute of Dermatology St. Thomas' Hospital

London UK

Jennifer Barton, MD

University of Rochester Medical Center Rochester, NY

USA

Clifton O. Bingham, MD Johns Hopkins University Baltimore, MD

USA

Brian K. Bonish, MD

Loyola University of Chicago Medical Center

Skin Disease Research Laboratory Cardinal Bernardin Cancer Center Maywood, IL

USA

Jennifer C. Cather, MD

University of Texas Southwestern Medical School Dallas

Dallas, TX USA

Daniel O. Clegg, MD Division of Rheumatology University of Utah Medical Center Salt Lake City, UT

USA

Jennifer Dempsey, MD

Vanderbilt University Medical School Dermatology Consultants

Nashville, TN USA

Christa L. Doherty, BSc (Hons) QEII Health Sciences Centre Halifax, Nova Scotia Canada

Steven R. Feldman, MD, PhD

Wake Forest University School of Medicine Medical Center Boulevard

Winston-Salem, NC USA

Dafna D. Gladman, MD FRCPC Center for Prognosis Studies Toronto Hospital Western Division Toronto, ON

Canada

(9)

List of Contributors XII

Kenneth B. Gordon, MD Division of Dermatology Loyola University

Stritch School of Medicine Maywood, IL

USA

Joan Guitart, MD Northwestern University Department of Dermatology Chicago, IL

USA

Michael P. Heffernan, MD Division of Dermatology

Washington University School of Medicine St. Louis, MO

USA

Philip Helliwell, MD

Academic Unit of Musculoskeletal Disease University of Leeds

Leeds UK

Christopher Jackson, MD Division of Rheumatology University of Utah Medical Center Salt Lake City, UT

USA

Christine C. Jacobson, AB Department of Dermatology

Stanford University School of Medicine Stanford, CA

USA

Ja Huen Jung, MD UCSD

Rheumatology Division Department of Medicine La Jolla, CA

USA

Arthur F. Kavanaugh, MD UCSD

Rheumatology Division Department of Medicine La Jolla, CA

USA

Alexa Kimball, MD, MPH

Dermatology Clinical Studies Unit Massachusetts General and Brigham and Women’s Hospitals

Boston, MA USA

Richard G.B. Langley, MD, FRCPC QEII Health Sciences Centre Halifax, Nova Scotia Canada

Mark Lebwohl, MD, FACP Department of Dermatology The Mt. Sinai Medical Center New York, NY

USA

Philip J. Mease, MD

Seattle Rheumatology Associates University of Washington Seattle, WA

USA

M. Alan Menter

Division of Dermatology

Baylor University Medical Center

University of Texas Southwestern Medical School Dallas

Dallas, TX USA

Scott J. Murray, MD, FRCPC QEII Health Sciences Centre Halifax, Nova Scotia Canada

Brian J. Nickoloff, MD, PhD Loyola University Medical Center Maywood, IL

USA

Bettina M. Prinz Vavricka, MD Department of Dermatology University Hospital Zurich Zurich

Switzerland

(10)

List of Contributors XIII

Rachel Quinby, MD Charlottesville, VA USA

Proton Rahman, MD Rheumatology

St. Claires Mercy Hospital St. Johns, NF

Canada

Stephen R. Rapp, PhD Department of Psychiatry and Behavioral Medicine

Wake Forest University School of Medicine Winston-Salem, NC

USA

Soumya M. Reddy, MD Rheumatology & Medicine Hospital for Joint Diseases New York, NY

USA

Christopher T. Ritchlin, MD Allergy Immunology Rheumatology University of Rochester Medical Center Rochester, NY

USA

Eric M. Ruderman, MD Division of Rheumatology Department of Medicine Northwestern University Feinberg School of Medicine Chicago, IL

USA

Jennifer Soung

Department of Dermatology The Mt. Sinai Medical Center New York, NY

USA

Bruce E. Strober, MD, PhD Associate Director

Dermatopharmacology Unit New York University School of Medicine New York, NY USA

Zuhre Tutuncu, MD UCSD

Rheumatology Division Department of Medicine La Jolla, CA

USA

Michael D. Zanolli, MD

Vanderbilt University Medical School Dermatology Consultants

Nashville, TN

USA

Riferimenti

Documenti correlati

Essentially, concrete guidelines for the management of the early postoperative period after lung transplantation do not exist (7).Variations in treatments is the main reason why this

After comparison of these two groups of respondents with different working hours with chemicals relative risk says that there is risk of all 4 respiratory related

Hospitalised geriatric patients are all at a high fall risk from the moment of admission (16) .One study which compared the rate of falls between different

This systematic review included eight studies (3,48,50-55) describing the rehabilitation methods for Sacroiliac Joint Pain, showing the effectiveness of different methods in

Objectives: The objectives of the study were as following: To evaluate the extent of disabilities caused by shoulder pain and its impact.To evaluate the

This meta-analysis included five clinical trial studies [48-52] showing the effect of balneotherapy and 6 clinical trial studies [42,48, 53-56] showing the effect

Baseline statin therapy is associated with a significant reduction in all-cause mortality and coronary revascularization risk for patients with non-obstructive CAD and for those

Deep sternal wound infection (DSWI) is a life-threatening condition that occurs mainly in patients undergoing major cardiac surgery with an incidence between 0.6 and 5 %.